Stay updated on Quizartinib in Children & Young Adults With AML Clinical Trial
Sign up to get notified when there's something new on the Quizartinib in Children & Young Adults With AML Clinical Trial page.

Latest updates to the Quizartinib in Children & Young Adults With AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision history now includes v3.5.0 as an addition and v3.4.3 as a deletion.SummaryDifference0.1%

- Check18 days agoChange DetectedThe history page adds revision v3.4.3 and removes revision v3.4.2.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedAdded Revision: v3.4.2 to the record history and removed the prior government funding notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check54 days agoChange DetectedA site-wide funding notice was added, informing that data may not be up to date due to a government funding lapse. The history page shows a new revision tag (v3.4.1) with the previous revision (v3.4.0) removed.SummaryDifference0.5%

- Check61 days agoChange DetectedThe update adds a glossary display and color-coded change indicators (green for additions, red for deletions) and updates the revision label to v3.4.0, while the previous v3.3.4 label is removed.SummaryDifference0.7%

- Check75 days agoChange DetectedThe history was updated to include Revision: v3.3.4 and to remove Revision: v3.3.3; this reflects housekeeping of the log rather than changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Quizartinib in Children & Young Adults With AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quizartinib in Children & Young Adults With AML Clinical Trial page.